Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review

Journal of Thrombosis and Haemostasis(2023)10.1016/j.jtha.2023.10.011Source: DataRank Database

Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review is a research paper published in Journal of Thrombosis and Haemostasis (2023). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.39)OA: bronzeTopics (50)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Shubham Agrawal ORCID,Thita Chiasakul ORCID,Kian Tehranchi,Megan McNichol ORCID,Brian J. Carney ORCID

Live enrichment

PubMed:37866517 OpenAlex:https://openalex.org/W4387849383

National Cancer Institute

Grant: P30 CA008748

National Institutes of Health

CSL Behring

Conquer Cancer Foundation

Sanofi

FWCI

1.39

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.jthjournal.org/article/S1538783623007791/pdf

publisherhttp://www.jthjournal.org/article/S1538783623007791/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1538783623007791?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1538783623007791?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtha.2023.10.011

Fields of Study

Intracerebral and Subarachnoid Hemorrhage ResearchVenous Thromboembolism Diagnosis and ManagementBrain Metastases and TreatmentHumansBrain NeoplasmsHeparin, Low-Molecular-WeightAdministration, OralIntracranial HemorrhagesRisk FactorsAnticoagulantsTreatment OutcomeFactor Xa InhibitorsRisk AssessmentAgedFemaleMaleMiddle Aged

MeSH Terms

Administration, OralAgedAnticoagulantsBrain NeoplasmsFemaleHeparin, Low-Molecular-WeightHumansMaleMiddle AgedNeoplasmsRetrospective StudiesRisk FactorsTreatment OutcomeRisk AssessmentIntracranial HemorrhagesVenous ThromboembolismFactor Xa Inhibitors

Keywords

MedicineInternal medicineMeta-analysisClinical endpointLow molecular weight heparinRelative riskHeparinCancerOncologyRandomized controlled trialConfidence intervalAnticoagulationBrain cancerVenous ThromboembolismIntracranial HemorrhageDirect-acting Oral Anticoagulants

Sustainable Development Goals

SDG 0: Good health and well-being